Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease.

We investigated the control of movement in 12 patients with Parkinson's disease (PD) after they received surgically implanted high-frequency stimulating electrodes in the subthalamic nucleus (STN). The experiment studied ankle strength, movement velocity, and the associated electromyographic patterns in PD patients, six of whom had tremor at the ankle. The patients were studied off treatment, ON STN deep brain stimulation (DBS), on medication, and on medication plus STN DBS. Twelve matched control subjects were also examined. Medication alone and STN DBS alone increased patients' ankle strength, ankle velocity, agonist muscle burst amplitude, and agonist burst duration, while reducing the number of agonist bursts during movement. These findings were similar for PD patients with and without tremor. The combination of medication plus STN DBS normalized maximal strength at the ankle joint, but ankle movement velocity and electromyographic patterns were not normalized. The findings are the first to demonstrate that STN DBS and medication increase strength and movement velocity at the ankle joint.     

The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia.

The kinematics characteristics of an upper arm extension of large amplitude (90 degrees) performed in the horizontal plane and the simultaneous activity of the shoulder muscles were recorded in 12 parkinsonian patients and in six normal control subjects. The movement, triggered by an acoustic "go" signal, was preceded by an isometric adduction. Within the whole population of individuals (n = 18) a strong, positive correlation was observed between the root mean square value of agonist EMG activity, evaluated during the acceleration phase of the movement, and both peak velocity and acceleration. In six patients tremor bursts at the frequency of 8-14 Hz (action tremor) were observed during the movement phase in the anterior, middle, and posterior deltoid: all these patients showed low root mean square values and were bradykinetic with respect to the control subjects. The remaining six patients did not show this action tremor during the movement phase. All but one had an agonist activation of normal duration and amplitude, showed high root mean square values, and performed well in the range of control subjects. We conclude that the inability to suppress the activity of pathological oscillator(s) responsible for the action tremor plays a fundamental role in the bradykinesia associated with Parkinson's disease.     

Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.

OBJECTIVE: To study fast voluntary neck movements in patients with cervical dystonia (CD) before and after therapy with botulinum toxin type-A (BTX-A). METHODS: A selected sample of 15 patients with CD (with prevalent torticollis) and 13 age-matched control subjects performed both right and left rotational, and flexion and extension neck movements as fast as possible. Movements were recorded with a motion analysis system (SMART, BTS). Movement time, angular amplitude, and peak angular velocity were analyzed. In patients, rotational neck movements were pooled as "pro-dystonic" (toward the dystonic side) and "anti-dystonic" (toward the non-dystonic side). Results obtained in patients before BTX-A treatment were compared with those of control subjects. The effect of BTX-A treatment was evaluated by comparing movement performance before and after treatment. RESULTS: Before receiving BTX-A, patients performed pro- and anti-dystonic movements with lower peak angular velocity than control subjects. Pro-dystonic movements had a reduced angular amplitude. Anti-dystonic movements showed an abnormally long movement time. Flexion and extension movements required longer movement times, but the other kinematic variables were normal. After BTX-A injections, pro-dystonic movement amplitude and anti-dystonic movement peak angular velocity increased, whereas flexion and extension movements remained unchanged. CONCLUSIONS: Before BTX-A injection patients with CD perform fast voluntary neck movements abnormally and BTX-A injections improved their peak velocity and amplitude. SIGNIFICANCE: Kinematic studies can detect specific neck movement disturbance in patients with CD, and can quantify both the severity of clinical picture and the effect of BTX-A injections in these patients.     

Control of movement distance in Parkinson's disease.

Studies of electromyographic (EMG) patterns during movements in Parkinson's disease (PD) have often yielded contradictory results, making it impossible to derive a set of rules to explain how muscles are activated to perform different movement tasks. We sought to clarify the changes in modulation of EMG parameters associated with control of movement distance during fast movements in patients with PD. Specifically, we studied surface EMG activity during rapid elbow flexion movements over a wide range of distances (5-72 degrees) in 14 patients with relatively mild symptoms of PD and 14 control subjects of similar age, sex, height, and weight. The PD group exhibited several changes in EMG modulation including impaired modulation of agonist burst duration; increased number of agonist bursts; reduced scaling of agonist EMG magnitude in the more severely impaired subjects; and increased temporal overlap of the antagonist and agonist signals in the most severely impaired subjects. These findings suggest that progressive motor dysfunction in PD is accompanied by increasing deficits in modulating muscle activation. These results help clarify previous disparate and sometimes contradictory results of EMG patterns in subjects with PD.     

Disturbances in human arm movement trajectory due to mild cerebellar dysfunction.

The temporal structure of arm movements was studied in nine cerebellar patients with mild impairment of the upper limbs and in six age-matched control subjects. The experimental paradigm consisted of visually guided, step tracking movements about the elbow. Movements ranged from 10 degrees to 70 degrees in amplitude and were made under different instructions (fast, fast/accurate, accurate). As in normal subjects, cerebellar patients were able to scale peak velocity with movement amplitude. This relationship was highly linear under all instruction conditions. Similar relationships existed between movement duration and amplitude. In contrast to normal subjects who produced movements with nearly symmetric velocity profiles, movements made by cerebellar patients were characterised by short acceleration and long deceleration durations. The degree of asymmetry was directly related to movement duration but was unaffected by movement peak velocity. Acceleration durations did not increase beyond 300 ms even in movements lasting up to 1s. These findings demonstrate that, despite little or no obvious impairment of the limb during routine examination, the temporal structure of voluntary movements in cerebellar patients is clearly disturbed. This supports the view that the production of an optimal movement trajectory is under cerebellar influence.     

Parkinsonian arm movements as altered by task difficulty

A discrete elbow movement to targets with different indexes of difficulty (ID) was used to determine the kinematic organization of arm movements in a young, an elderly and a Parkinson's disease (PD) group (n = 14). Target size and movement amplitude changes led to expected modifications of the kinematics in all three groups according to Fitts' law. Increased task demands by changing target size produced not only differences between the age-groups, but affected the modulation of velocity and acceleration in the parkinsonian patients differentially. For large amplitude movements, the PD patients were less able to increase velocity and acceleration magnitudes when target accuracy constraints were reduced. These findings, when taken together with the observation that speed scaling was preserved for small movement amplitudes, suggest that a reduced capability to initiate and regulate force is the cause for the observed slowness in PD.     

EMG remains fractionated in Parkinson''s disease, despite practice-related improvements in performance

OBJECTIVE: We studied the ability of patients with Parkinson's disease to improve their performance in a motor task requiring both speed and accuracy in the execution of elbow flexion movements. Our goal was to investigate the changes in electromyographic activity associated with the changes in movement performance. METHODS: Eleven patients on anti-Parkinsonian medication were tested. The patients were selected for being bradykinetic, having little or no resting tremor or dyskinesias, and being in stages II or III of the Hoehn and Yahr rating scale. RESULTS: The untrained patients displayed multiple bursts of agonist activity, characteristic of Parkinsonian EMG recordings. All patients improved their performance by increasing peak velocity while maintaining movement accuracy within strict boundaries. With practice, the patients' performance changed in a manner similar to that which has been previously observed for performance curves in neurologically normal subjects. As movement duration decreased (i.e. peak velocity increased), we observed a slight decrease in the number of agonist bursts and an increase in the average burst duration. However, the patients continued to generate a fractionated, multi-burst agonist pattern. CONCLUSIONS: We conclude that Parkinsonian patients benefit from practice by improving their performance but remain fundamentally impaired in the generation of muscle activation patterns. This study has shown that the generation of fractionated, multiple short bursts of EMG activity that is characteristic of movements made by Parkinsonian patients is not normalized by practice.     

Effects of expected perturbations on the velocity control of fast arm abduction movements

A triphasic electromyographic pattern of sequential activation of agonist, antagonist, and again agonist muscles underlies rapid or ballistic limb movements in humans. The first agonist burst reflects muscular force accelerating the limb, the antagonist burst is mainly related to the braking process of movement, while the second agonist burst is considered a reactive adjustment to the deceleration. The duration of the first agonist burst has been reported to be constant for movements of different amplitudes, thus suggesting that only changes in its amplitude contribute to the velocity control of movement. The present research has been undertaken to investigate the strategy whereby the nervous system increases agonist impulsive force for ballistic performance in response to experimental conditions requiring perceptual and/or provisional processes related to expected changes in load or accuracy constraints. The effects of expected perturbations of different strengths on some kinematic and electromyographic variables of fast arm abduction movements performed in a step-tracking task and in an outer-stop terminated task were analyzed in normal subjects. All motor performances were characterized by triphasic electromyographic patterns. In the absence of expected perturbations, the mean velocity of the movements was markedly higher in the outer-stop terminated task. Correspondingly, greater amplitudes and durations of the first agonist burst were observed. In both types of motor tasks, when expected perturbations were inserted, the velocity of the movement increased as well as the amplitude and the duration of the first agonist burst. These results, in agreement with previous observations, indicate that the normal mechanism, whereby the nervous system increases agonist impulsive force in rapid movements, comprises changes not only in the amplitude but also in the duration of the first agonist burst.     

Step-tracking movements of the wrist in humans. I. Kinematic analysis

We have examined the kinematics of the initial trajectory of step-tracking movements performed by human subjects. Each subject tracked a target that required 5-30 degrees of radial or ulnar deviation of the wrist. All movements were to be performed as accurately as possible. Speed instructions were given before each trial. When subjects performed different amplitude movements following the same speed instruction, the peaks of velocity, acceleration, and jerk were linearly related to peak displacement. The peaks of velocity, acceleration, and jerk also changed when the speed instruction was altered. Thus, for any given movement, the peak values of the derivatives of displacement were dependent on both movement amplitude and intended speed. As a result, the peak values of the derivatives cannot be used by themselves to control or monitor peak displacement. When subjects performed different amplitude movements following the same speed instruction, movement duration tended to remain constant. In contrast, movement duration changed when the speed instruction was altered. Movements performed when subjects intended to move slowly had longer durations than when subjects intended to move quickly. These results suggest that subjects volitionally alter intended speed by selecting different movement durations. When both movement amplitude and intended speed were varied, the peak displacement of a step-tracking movement was linearly related to the product of 2 kinematic variables: the initial peak of a derivative of displacement (either velocity, acceleration, or jerk) and movement duration. On the basis of our observations, we propose that central commands generate step-tracking movements of different amplitudes and intended speeds by adjusting both the magnitude and duration of a derivative of displacement.     

Parkinson's disease and the control of size and speed in handwriting.

This experiment investigated whether Parkinson's disease (PD) patients experience problems in producing stroke size, stroke duration or both, in a handwriting task. Thirteen PD patients and 15 elderly controls wrote four patterns of varying complexity on a digitizer tablet. The participants were instructed to execute the writing movements: at a normal size and speed; as fast as possible; two times larger than normal; and two times larger and as fast as possible. PD patients had no difficulty increasing speed while maintaining size and had no difficulty increasing size while maintaining speed. However, they showed significantly smaller size increases in the two times larger condition as compared to the elderly controls. The conditions were also simulated by a neural network model of normal and PD movement control that produced a stroke pattern that approximated the experimental data. For the instructions used, the results suggest that when patients scale speed, they have no difficulty controlling force amplitude, but when they scale stroke size, they have a problem controlling force amplitude. Thus, PD patients may have reduced capability to maintain a given force level for the stroke time periods tested with the instructions.     

Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.

We examined whether people with Parkinson's disease (PD) have a central amplitude regulation disorder using three-dimensional (3-D) gait analyses to compare the effects of medication and attentional strategies on gait in 12 PD subjects and 12 matched comparison subjects. Subjects with PD first performed several 10-m gait trials at preferred speed while off levodopa. They then walked at preferred speed on levodopa; off levodopa with cues; and on levodopa with cues. Control subjects walked at preferred speed and then with visual cues to match their stride length to PD values. As well as spatiotemporal footstep data, pelvic and lower limb kinematic profiles and angle-angle diagrams were produced for sagittal, coronal, and transverse plane movements using a 3-D motion analysis system. In people with PD, decreased step length was accompanied by reduced movement amplitude across all lower limb joints, in all movement planes. When control subjects were required to walk with short steps matched to the size of PD comparisons, they displayed a similar multijoint reduction in amplitude. For PD subjects, both levodopa and visual cues increased movement amplitude across all lower limb joints. Amplitude increased further when levodopa and visual cues were combined, resulting in normalization of step length. This finding suggested that reduced step length is due to a mismatch between cortically selected movement amplitude and basal ganglia maintenance mechanisms. Levodopa and cues normalized amplitude across all joints by altering motor set and bypassing defective basal ganglia mechanisms.     

Quantitative measurement of trunk rigidity in parkinsonian patients

We aimed to develop an objective measurement to quantify trunk rigidity in patients with Parkinson's disease (PD), and to examine its reliability, validity and sensitivity in differentiating PD patients from control subjects. In Study 1, an isokinetic dynamometer was employed to assess trunk rigidity in 6 PD patients and 6 healthy controls. Passive trunk flexion and extension at 4 angular velocities were applied and resistive torques were recorded. Both work done and resistive peak torques to passive trunk flexion (Torque(PF)) and extension (Torque(PE)) were found to be highly reliable within a 2-day interval in PD patients and control subjects. In Study 2, trunk muscle tone was compared between 15 PD and 15 control subjects. Significantly higher muscle tone, as shown by increases in work done, and in Torque(PF) and Torque(PE )at higher movement speeds, was found in PD patients. Within each subject group, resistive trunk muscle tone was found to increase with increasing velocity of passive movement, but the extent of increase was greater in PD patients. Our results thus suggest that the objective method developed by us was reliable and could differentiate trunk rigidity in PD patients from that of healthy subjects.     

Kinematic analysis of articulatory movements in central motor disorders

The various components of the central motor system are expected to play a similar role in speech production and in upper limb control. Slowed articulatory performance, therefore, must be expected in disorders of the corticobulbar tracts, cerebellum, and basal ganglia. Using an optoelectronic device, the present study recorded lower lip trajectories during production of sentence utterances in patients with Parkinson's disease (PD), Huntington's disease (HD), cerebellar atrophy (CA), and pseudobulbar palsy (PB). The various subject groups showed a similar range of overall motor disability. Patients with CA and PB exhibited slowed movement execution in terms of a reduced ratio of peak velocity to maximum amplitude (“stiffness”)- In contrast to upper limb motor control, the lip excursions showed an uncompromised shape of velocity profiles. Two different patterns emerged in HD. A single patient suffering from the akinetic-rigid Westphal variant of this disease had articulatory hypometria, whereas the remaining subjects showed significant bradykinesia under increased temporal demands, concomitant with normal movement amplitudes. The PD patients had unimpaired velocity-displacement relationships. Presumably, biomechanical constraints such as the rather small excursions of articulatory lower lip gestures or the scarce spindle supply of facial muscles account for the observed discrepancies between upper limb and speech motor control in PD.     

Effect of movement frequency on repetitive finger movements in patients with Parkinson's disease

Performance of repetitive hand movements in patients with Parkinson's disease (PD) is characterized by slowness, reduced movement amplitude, and hesitation or arrests in ongoing movement. Currently, the factors and mechanisms contributing to impaired performance of these types of movement remain poorly understood. This study examined the effects of movement frequency and medication on the performance of unconstrained index finger flexion movements in patients with PD and matched control subjects. Movements were synchronized with an auditory tone as the frequency of the tone was increased from 1 to 3 Hz in 0.25 Hz increments. Movement performance was quantified based upon finger kinematics and electromyography (EMG) recorded from the index finger flexors and extensors. The principal finding was that patients with PD showed a dramatic reduction in movement amplitude, an increase in movement frequency, and a loss of phase when the movement frequency reached or exceeded 2 Hz. This deficit was not significantly improved with medications. In contrast, all control subjects could synchronize to 3 Hz. These findings show that movement frequency is a major determinant of hypokinesia during repetitive movements and may contribute to hesitations and movement arrest during clinical testing of bradykinesia in the upper limb of patients with PD. © 2009 Movement Disorder Society     

Interlimb coordination in Parkinson's disease.

This study examined the degree to which Parkinson's disease (PD) patients could "spatially link" the upper limbs to facilitate the performance of bimanual simultaneous movements. Six right-handed PD patients, and seven normal age- and sex-matched controls performed three different tasks: (a) an isotonic elbow flexion as rapidly as possible through an angle of 30 degrees; (b) an isometric contraction of the flexor muscles at the elbow joint to 40% and 60% of maximal volitional force (MVF) for a period of 5 s; (c) an isometric contraction for 2.5 s with one limb, then simultaneously performing an isotonic flexion with the contralateral limb while maintaining the isometric contraction for 2.5 s more. As expected, PD patients were significantly slower in performing the isotonic movement and produced lower peak velocities than the controls. More importantly, the two groups were differentially affected during the bimanual condition. In normals, movement time decreased and peak velocity increased in the bimanual condition. In contrast, PD patients showed increased movement times and sometimes decreased peak velocities in the bimanual condition. The results suggest that normal subjects utilize bilateral outflow to symmetrical muscle groups to synchronize the two limbs in the bimanual task, whereas PD patients dissociate the two limbs.     

The clinimetrics of hypokinesia in Parkinson's disease: Subjective versus objective assessment

Summary In this study we evaluate the feasibility of measures that reflect different characteristics of motor activity and immobility in the objective quantification of hypokinesia. Because by definition hypokinesia can only be assessed over a period of time, continuous activity monitoring was used during 5 successive days in the home setting in 64 patients with Parkinson's disease (PD) and 104 healthy elderly subjects. In the patients we also evaluated the relation between the monitor measures and subjective measures of hypokinesia and age. Compared to the healthy elderly subjects, PD patients have a decreased activity level, increased proportion of time without movement, elevated mean duration of immobility, and decreased percentage of short-lasting immobility periods. Differences between both groups were most prominent for those measures that incorporate or reflect immobility. Moreover, in the PD patients the mean duration of immobility and percentage of short-lasting immobility periods show an apparent lack of relation with age and clinical ratings obtained from the UPDRS. In conclusion, our findings underscore the poor representation of hypokinesia in the UPDRS and value of objective quantification of this fundamental impairment of PD.     

Switching of movement direction is central to parkinsonian bradykinesia in sit-to-stand.

Patients with Parkinson's disease (PD) are known to manifest slowness in movements. We sought to identify the particular kinematic and kinetic disorders that contribute to the slowness in performing sit-to-stand in these patients. Two inter-related studies were carried out. In the first study, 20 patients with PD and 20 control subjects were instructed to perform sit-to-stand at a natural speed. In the second study, 15 control subjects were instructed to simulate the slower speed of sit-to-stand of the patients identified in the first study. Kinematic and kinetic data were recorded by a PEAK motion analysis system and two force platforms. The results showed that patients with PD generated smaller peak horizontal and vertical velocities during the task. They took a longer time to complete each individual phase as well as the whole movement of sit-to-stand. Patients also produced smaller peak hip flexion and ankle dorsiflexion joint torques and had prolonged time-to-peak torques from sit-to-stand onset. When control subjects simulated the patients' speed of sit-to-stand, there was no difference in all the kinematic and kinetic data between groups. The only exception was that they exhibited a shorter transition time between peak horizontal velocity (flexion phase) and seat-off (extension phase) than the patients. This study demonstrated that the slowness of PD patients during sit-to-stand at a natural speed could be attributed to inadequate peak hip flexion and ankle dorsiflexion torques, a prolonged torque production, as well as a difficulty in switching from the flexion to extension direction during sit-to-stand. As the latter difficulty persisted when the control subjects performed the task at a speed similar to that of the patients, our findings suggest that a fundamental problem of patients with Parkinson's disease could be a switch between movement directions.     

Use of advance information for complex movements in Parkinson's disease

Motor preparation processes in Parkinson's disease (PD) patients and elderly control subjects were examined by utilizing the movement parameter precue technique in prehension movements to different sized objects. PD patients as well as controls were able to use advance information about object size to reduce their response times. However, further analysis of the response kinematics revealed that in contrast to controls, PD patients showed a prolongation of the transport phase related to the validity of the object size precue when grasping small objects. Therefore, PD patients seem to suffer from a slowing of their qualitatively preserved motor preparation process which becomes more pronounced in complex tasks like prehension. This finding of a qualitatively preserved, but slowed capability in PD patients of using advance information for motor preparation is discussed in the framework of the motor control literature on predictive behavior in PD.     

Voluntary,spontaneous, and reflex blinking in Parkinson's disease

Blinking, a motor act consisting of a closing and an opening eyelid movement, can be performed voluntarily, spontaneously, and reflexly. In this study we investigated the kinematic features of voluntary, spontaneous, and reflex blinking in patients with Parkinson's disease (PD), OFF and ON dopaminergic treatment. Patients were asked to blink voluntarily as fast as possible. Spontaneous blinking was recorded for a minute during which the subjects just relaxed. Reflex blinking was evoked by electrical stimulation on the supraorbital nerve. Eyelid movements were recorded with the SMART analyzer motion system. Patients OFF therapy paused longer than controls during voluntary blinking but not during spontaneous and reflex blinking. The blink rate tended to be lower in patients OFF therapy than in controls and the spontaneous blinking had abnormally low amplitude and peak velocity. Finally, in patients OFF therapy the excitability of the neural circuit mediating the closing phase of the reflex blinking was enhanced. Dopaminergic treatment shortened the pause during voluntary blinking and increased the blink rate. In PD patients the longer pauses between the closing and opening phase in comparison to normal subjects, suggest bradykinesia of voluntary blinking. PD patients also display kinematic abnormalities of spontaneous blinking and changes in the excitability of the closing phase of reflex blinking. © 2007 Movement Disorder Society     

Antiparkinson medications improve agonist activation but not antagonist inhibition during sequential reaching movements.

The execution of sequential arm movements is critical to activities of daily living such as eating and grooming. It is known that movement sequences are bradykinetic in people with Parkinson's disease (PD) and that antiparkinson medications improve the speed of movement sequences. However, it is unclear how muscle activity is modulated during sequential movements and what effect antiparkinson medications have on muscle modulation. We studied subjects with PD and age- and gender-matched control subjects making sequential reaching movements. Subjects with PD were tested before and after their morning dose of antiparkinson medications (levodopa and/or dopamine agonists). We examined the effect of antiparkinson medications on the modulation of muscle activity (i.e., the ability to activate and inhibit each muscle throughout the course of a sequence). Results showed that the group with PD, before medication, moved more slowly and modulated muscle activity poorly compared to the control group. Antiparkinson medications improved movement speed as expected, although sequential movements remained slower than normal even after medication. Medication improved the ability to activate agonist muscle activity but did not improve the ability to inhibit antagonist activity. Instead, antagonist activity was also increased, resulting in minimal improvements in muscle modulation during sequential reaching movements.